An NHS trial over 10 years followed nearly 3,500 men who received focal therapy, a less invasive treatment.

Opinion: Without the Bayh-Dole Act, countless medical discoveries would never leave university laboratories, writes Dr.

For decades, men with prostate cancer were routinely advised against testosterone replacement therapy (TRT), even if they had ...

In a recent review published in the journal Nature Reviews Urology, researchers examined the molecular mechanisms and metabolic processes that drive ferroptosis — a form of cell death that plays a ...

MRI of the prostate, combined with a blood test, can help determine if a prostate lesion is clinically significant cancer, new research suggests A new meta-analysis by investigators from Brigham and ...

Scientists have developed a fully human antibody that halted the growth and spread of aggressive prostate cancer in preclinical research. Although more testing is needed, the drug’s unusual mechanism ...

Prostate cancer has distinct genetic properties in different groups of men that could be targeted to improve patient outcomes, new research suggests. Prostate cancer has distinct genetic properties in ...

According to the American Cancer Society, approximately 1 in 8 men in the U.S. will be diagnosed with prostate cancer during their lifetime. In addition, about 1 in 44 men will die from the disease, ...

LOS ANGELES--(BUSINESS WIRE)--The Prostate Cancer Foundation (PCF) announced the recipients of its 2024 Challenge Awards, funding over $16 million in innovative prostate cancer research for ...